Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Characterization of BAM8-22 as a New Surrogate Model of Non-histaminergic Itch
NCT04588532Completed
- Sponsor
- Aalborg University
- Start
- Oct 2020
- Primary completion
- May 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of BAM8-22 in pruritus (2 arms), sponsored by Aalborg University. Primary endpoints: Superficial blood perfusion at 10 minutes, Warm Detection Threshold at 10 minutes and 7 more. Started Oct 2020; status: completed.
02
Drugs
BAM8-22
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT04588532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04588532.